Numeta Neo
Numeta Neo is a medicine authorised by Swissmedic under authorisation number 61336. The authorisation holder is Baxter AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 October 2011 and the authorisation is valid without a time limit. ATC code B05BA10 places the medicine in the group Blood substitutes and perfusion solutions.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Numeta Neo, Emulsion zur Infusion | B | 15 June 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 10 x 300 | ml | B05BA10 | 07.01.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Numeta Neo authorised in Switzerland?
Yes. Numeta Neo is authorised by Swissmedic under authorisation number 61336, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Numeta Neo have?
Numeta Neo is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Numeta Neo?
The authorisation holder is Baxter AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.